Lataa...
Icatibant and ACE inhibitor angioedema
Icatibant is a selective bradykinin 2 receptor antagonist, currently licensed for use in hereditary angioedema. Its benefit in ACE inhibitor angioedema is yet to be fully established. A handful of preliminary case reports suggest that it may be of benefit in reducing both symptom severity and possib...
Tallennettuna:
| Julkaisussa: | BMJ Case Rep |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMJ Group
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4543926/ https://ncbi.nlm.nih.gov/pubmed/22936825 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2012-006646 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|